trending Market Intelligence /marketintelligence/en/news-insights/trending/7NqbPHTik1myoZEoRPy_xg2 content esgSubNav
In This List

Neuralstem appoints executive chairman; interim CEO to step down

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Neuralstem appoints executive chairman; interim CEO to step down

Neuralstem Inc. named Kenneth Carter executive chairman, effective Jan. 1, 2019.

Carter will replace Jim Scully, who is stepping down as interim CEO.

Carter is chairman of Noble Life Sciences Inc., a pre-clinical contract research organization for biotechnology and pharmaceutical companies.

Neuralstem focuses on researching and developing nervous system therapies.